Nocera, INC

Market Movers (8-K)

NASDAQ
Nocera, Inc. has acquired a 30% controlling interest in Taiwan-based QMAX Technology Co., Ltd. through a VIE structure, issuing 300,000 shares of common stock as consideration.
NASDAQ
Nocera, Inc. has entered into a letter of intent to acquire a minority stake in INERGX Energy Optimisation Ltd and has completed a 1-for-30 reverse stock split to meet Nasdaq listing requirements.
Capital raise
NASDAQ
Nocera, Inc. has entered into an Equity Purchase Facility Agreement with an institutional investor, allowing it to issue and sell up to $100 million in common stock over a 24-month period.
Capital raise
NASDAQ
Nocera, Inc. has engaged Phoenix MGMT & Consulting LLC for strategic advisory and execution support services.
NASDAQ
Nocera, Inc. has been notified by Nasdaq that it fails to meet the minimum stockholders' equity requirement for continued listing.
Worse than expected
Capital raise
NASDAQ
Nocera, Inc. received a Nasdaq delisting notice due to its low bid price, appointed a new auditor, approved a CEO bonus, and completed its $2 million Bitcoin purchase.
Capital raise
Worse than expected

Quarterly Earnings (10-Q)

NASDAQ
Nocera, Inc. reported a significant decrease in revenue and a substantial increase in net loss for the first quarter of 2026, primarily due to a decline in its fish trading business and increased operating expenses.
Capital raise
Worse than expected
NASDAQ
Nocera, Inc. reported a significant increase in net loss for the nine months ended September 30, 2025, despite a successful Series B Preferred Stock issuance and a new $300M convertible note agreement.
Worse than expected
Capital raise
NASDAQ
Nocera, Inc. reported a significant net loss and revenue decline for the second quarter and first half of 2025, alongside ongoing liquidity concerns and internal control weaknesses.
Worse than expected
Capital raise
Delay expected
NASDAQ
Nocera, Inc. filed an amended quarterly report for Q1 2025 to add segment reporting disclosures, revealing continued net losses, a decline in overall revenue and gross profit, and persistent material weaknesses in internal controls, despite some improvements in operating cash flow and e-commerce performance.
Delay expected
Capital raise
NASDAQ
Nocera Inc.'s Q1 2025 results reveal a revenue decrease and ongoing concerns about internal control effectiveness.
Worse than expected
Capital raise
NASDAQ
Nocera, Inc. has filed an amended quarterly report on Form 10-Q/A to revise and update certain disclosures in response to comments from the SEC.
Worse than expected
Capital raise

Annual Reports (10-K)

NASDAQ
Nocera, Inc. filed an amendment to its 2025 Annual Report to correct errors in previously reported financial statements.
Worse than expected
Capital raise
NASDAQ
Nocera, Inc. reports a net loss of $2.88 million for fiscal year 2025, citing ongoing operational challenges and substantial doubt regarding its ability to continue as a going concern.
Worse than expected
Capital raise
NASDAQ
Nocera, Inc. has filed an amended annual report for fiscal year 2024, restating its interim financial statements due to errors in warrant liability valuation and asset misclassifications, while reporting a significant decline in net sales and ongoing concerns about its ability to continue as a going concern.
Worse than expected
Capital raise
Delay expected
NASDAQ
Nocera, Inc. has filed an amended annual report for 2024, restating prior interim financial statements due to errors in warrant liability calculations and asset misclassifications, revealing continued net losses and raising substantial doubt about its ability to continue as a going concern.
Delay expected
Worse than expected
Capital raise
NASDAQ
Nocera, Inc.'s 10-K filing reveals a restatement of interim financials due to warrant liability errors and expresses substantial doubt about the company's ability to continue as a going concern.
Worse than expected
Capital raise
NASDAQ
Nocera, Inc. has filed an amended 10-K report, addressing SEC comments and reporting a significant increase in revenue for 2023, while still facing substantial operating losses and concerns about its ability to continue as a going concern.
Worse than expected
Capital raise

Insider Trading (Form 4)

NASDAQ
Andy Ching-An Jin, Chief Executive Officer and a Director of Nocera, Inc., received 20,000 shares of common stock on July 29, 2026.
NASDAQ
Song-Yuan Teng, Chief Executive Officer (Asia) and a Director of Nocera, Inc., received 20,000 shares of common stock on July 29, 2026.
NASDAQ
HRT Financial LP reports significant transactions involving Nocera Inc. common stock, including acquisitions and dispositions.
NASDAQ
HRT FINANCIAL LP reports significant transactions in Nocera Inc. common stock, acquiring shares and disposing of others.
NASDAQ
HRT FINANCIAL LP reports transactions of Nocera, Inc. common stock, indicating changes in beneficial ownership.
NASDAQ
Nocera Inc. Chief Operating Officer, Chen Feng-Hua, was granted 100,000 shares of common stock under the company's 2018 Stock Option and Award Incentive Plan.

Proxy Statements (Def-14A)

NASDAQ
Nocera, Inc. will hold its 2025 Annual Meeting to vote on key proposals including a reverse stock split, an increase in authorized shares, and the potential issuance of common stock from convertible securities.
Worse than expected
Capital raise
NASDAQ
Nocera, Inc. is holding its 2024 Annual Meeting of Shareholders virtually on December 16, 2024, to elect five directors and ratify the appointment of Enrome LLP as the independent auditor.
NASDAQ
Nocera, Inc. announces its 2024 Annual Meeting of Shareholders to be held virtually on December 16, 2024, to elect five directors and ratify the appointment of Enmore LLP as the independent auditor.

New Public Companies (S-1)

NASDAQ
Nocera, Inc. filed an S-1/A registration statement for the resale of up to 45,000,000 shares of common stock by a selling stockholder, convertible from Series B Preferred Stock, with no direct proceeds to the company from these sales.
Capital raise
Worse than expected
NASDAQ
Nocera, Inc. files an S-1 registration for the resale of up to 45 million common shares by a selling stockholder, while auditors express substantial doubt about the company's ability to continue as a going concern amidst ongoing losses.
Delay expected
Capital raise
Worse than expected